Firms
Theme

ULTA

Ulta Beauty, Inc. · NASDAQ

News

7 latest

Zacks Investment Research

Ulta Beauty Inc. (ULTA) Is a Trending Stock: Facts to Know Before Betting on It

Ulta Beauty has been a trending stock with shares returning +15.7% over the past month, outperforming the S&P 500. The company is expected to post earnings growth of +9% for the current quarter and +12.9% for the fiscal year. However, with a Zacks Rank #3 (Hold) rating and a C valuation grade indicating fair pricing relative to peers, the stock is expected to perform in line with the broader market in the near term.

Zacks Investment Research

Ulta Beauty (ULTA) Beats Stock Market Upswing: What Investors Need to Know

Ulta Beauty stock closed at $603.21, up 1.96% and outperforming the S&P 500's 0.28% gain. The company is forecasted to report Q3 EPS of $5.6 (up 8.95% YoY) and revenue of $2.99 billion (up 4.54% YoY).

Zacks Investment Research

Ulta Beauty (ULTA) Gains As Market Dips: What You Should Know

Ulta Beauty (ULTA) closed at $578.87, up 2.01%, outperforming the S&P 500. The stock has gained 3.43% over the past month.

Mentions ULTA

Zacks Investment Research

3 Beauty Stocks to Explore as Consumer Preferences Reshape the Market

The beauty and cosmetics industry continues to attract investors through changing consumer preferences focused on product performance, ingredient quality, and affordability. Companies are innovating with personalized solutions, sustainable practices, and digital expansion. Three stocks highlighted are e.l.f. Beauty (Strong Buy), The Estee Lauder Companies (Buy), and Ulta Beauty (Hold), each addressing emerging trends through diverse brand portfolios and omnichannel strategies.

Zacks Investment Research

Can Sally Beauty's Digital Growth Become a Larger Share of Sales?

Sally Beauty Holdings (SBH) reported 11% global e-commerce growth in Q3 fiscal 2026, marking four consecutive quarters of double-digit online sales increases. The company's Sally segment saw e-commerce sales rise 20% to $52 million, while its Licensed Colorist On Demand service averaged over 5,200 weekly consultations with 28% new customer growth. Similar digital expansion strategies are being employed by competitors Ulta Beauty and Estée Lauder, reflecting broader retail trends toward omnichannel growth.

Zacks Investment Research

These 2 Retail and Wholesale Stocks Could Beat Earnings: Why They Should Be on Your Radar

The article explains how the Zacks Earnings ESP (Expected Surprise Prediction) tool can help investors identify stocks likely to beat earnings expectations. It highlights two retail stocks—Starbucks and Ulta Beauty—both with positive ESP figures of +2.43% and +2.37% respectively, suggesting potential for positive earnings surprises ahead of their November and December 2026 earnings reports.

Zacks Investment Research

Ulta Beauty Raises 2026 Outlook as E-Commerce Momentum Accelerates

Ulta Beauty raised its fiscal 2026 sales, comparable-sales, and earnings guidance following a better-than-expected Q2 with $6.55 EPS (vs. $6.21 consensus) and $3.04B revenue. E-commerce grew at high-teens rate for the sixth consecutive quarter with strong omnichannel execution. However, the company faces tougher H2 comparisons, flat transaction growth, and only modest margin improvement, making execution critical to delivering the upgraded outlook.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $ULTA · 0 threads

Sign in to post on $ULTA

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev